Weekend Therapy for the Treatment of Helicobacter pylori Infection

Tucci, Antonio; Poli, Loris; Paparo, G. Francesco; Bocus, Paolo; Togliani, Thomas; Mazzoni, Claudia; Orcioni, Giulio Fraternali; Agosti, Roberto; Grigioni, Walter F.; Sottili, Sara; Caletti, Giancarlo
May 1998
American Journal of Gastroenterology;May1998, Vol. 93 Issue 5, p737
Academic Journal
Objectives: The aim of the present study was to evaluate the efficacy and the safety of a short-term regimen (weekend therapy) in the cure of Helicobacter pylori infection and to analyze the factors that may influence the success of the treatment. Methods: Seventy-one patients with gastric colonization by a tinidazole sensitive H. pylori strain (34 duodenal ulcer and 37 nonulcer dyspepsia) received omeprazole 40 mg o.m. for 7 days (from Monday to Sunday) and bismuth 240 mg q.i.d. + amoxicillin 1000 mg/q.i.d. + tinidazole 500 mg q.i.d, for only 2 days (Saturday and Sunday). Endoscopy, histology, culture, urease test, and susceptibility studies were done at entry and 30 days after treatment. Results: Successful eradication was obtained in 84% of patients. The percentage of eradication was higher in duodenal ulcer patients (94%) than in those with nonulcer dyspepsia (74%; p < 0.05), and in patients who received the treatment during hot weather (94%) than in those who received the treatment during cold weather (74%; p < 0.05). Side-effects were induced by the treatment in 17% of patients, and these were all not severe, self-limiting, short-lasting, and did not require specific treatment. Conclusions: These data suggested that weekend therapy with high doses of drugs represents an effective, safe, and inexpensive therapeutic approach for the treatment of H. pylori infection, particularly in patients with duodenal ulcer. Furthermore, they also confirm the relevant role that short-term treatments may play in the therapeutic approach to H. pylori infection, and highlight some important aspects influencing short-term schedules.


Related Articles

  • Randomized Clinical Trial Comparing Two One-Week Triple-Therapy Regimens for the Eradication of Helicobacter pylori Infection and Duodenal Ulcer Healing. Forné, M.; Viver, J. M.; Esteve, M.; Fernández-Bañares, F.; Lite, J.; Espinós, J. C.; Quintana, S.; Salas, A.; Garau, J. // American Journal of Gastroenterology;Jan1998, Vol. 93 Issue 1, p35 

    Objective: One-week triple therapy has been shown to be effective in Helicobacter pylori eradication and duodenal ulcer healing. However, the optimal therapeutic combination has not yet been identified. Bismuth-containing regimens have the advantage of requiring only one antibiotic. It...

  • Empiric approach to dyspepsia: test and treat strategy vs PPI treatment. A randomized controlled study. Maes, G.; de Nucci, C.; Mechise, A.; Balzano, A. // Gut;Sep2002 Supplement 2, Vol. 51, pA92 

    Reduction in the endoscopic workload by means of case selection based on empiric therapies has been advocated in order to reduce the costs for dyspepsia. The present study compares the efficacy of the "H. pylori — Hptest and treat strategy" with an empiric omeprazole trial. Methods: 219...

  • Symptomatic Benefit 1-3 Years After H. pylori Eradication in Ulcer Patients: Impact of Gastroesophageal Reflux Disease. McColl, Kenneth E. L.; Dickson, Anthea; El-Nujumi, Adil; El-Omar, Emad; Kelman, Andrew // American Journal of Gastroenterology;Jan2000, Vol. 95 Issue 1, p101 

    OBJECTIVES: Eradication of Helicobacter pylori (H. pylori) infection markedly reduces the recurrence of duodenal and gastric ulcers. However, there is little information regarding its efficacy in resolving dyspeptic symptoms in ulcer patients. The primary aim of this study was to assess...

  • Helicobacter pylori eradication.  // American Family Physician;9/15/1993, Vol. 48 Issue 4, p669 

    Reports on the effect of the eradication of Helicobacter pylori (H. pylori) on the decrease in risk of relapse in duodenal ulcer. H. pylori infection as major cause of chronic gastritis; Eradication regimens; Major drawbacks to triple therapy.

  • Efficacy of Omeprazole One Year after Cure of Helicobacter pylori Infection in Duodenal Ulcer Patients. Labenz, Joachim; Tillenburg, Birgit; Peitz, Ulrich; Börsch, Gereon; Idström, Jan-Peter; Verdú, Elena; Stolte, Manfred; Blum, Andrée L. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p576 

    Objective: We have previously shown that, in duodenal ulcer patients, pH control by omeprazole is less pronounced after cure of Helicobacter pylori infection. The present study was designed to test the hypothesis that this response to omeprazole persists 1 yr after cure of H. pylori infection....

  • Seasonal Variation in the Frequency ofHelicobacter pylori Infection: A Possible Cause of the Seasonal Occurrence of Peptic Ulcer Disease. Moshkowitz, M.; Konikoff, F. M.; Arber, N.; Peled, Y.; Santo, M.; Bujanover, Y.; Gilat, T. // American Journal of Gastroenterology;May1994, Vol. 89 Issue 5, p731 

    Objectives: The seasonal variation of duodenal ulcer disease and its complications have been repeatedly demonstrated in Israel by several independent studies. The aim of this study was to determine possible seasonal variations in the occurrence of H. pylori infection among dyspeptic patients in...

  • Who benefits from Helicobacter pylori eradication? Delaney, Brendan C. // BMJ: British Medical Journal (International Edition);1/28/2006, Vol. 332 Issue 7535, p187 

    The editorial comments on the eradication regimen for Helicobacter pylori. The National Institute for Health and Clinical Excellence (NICE) provides guidelines for categorizing patients with heartburn and epigastric pain. The reasons for eradicating H pylori include prevention of dudenal ulcer....

  • Helicobacter pylori vacA, iceA, and cagA Status and Pattern of Gastritis in Patients With Malignant and Benign Gastroduodenal Disease. Miehlke, Stephan; Yu, Jun; Schuppler, Markus; Frings, Christina; Kirsch, Christian; Negraszus, Nico; Morgner, Andrea; Stolte, Manfred; Ehninger, Gerhard; Bayerdörffer, Ekkehard // American Journal of Gastroenterology;Apr2001, Vol. 96 Issue 4, p1008 

    OBJECTIVE: Both bacterial virulence factors and the pattern of Helicobacter pylori (H. pylori) gastritis may contribute to the development of clinically relevant gastroduodenal disease. The aim of our study was to investigate the frequency of H. pylori vacA alleles,...

  • Bismuth, Metronidazole, and Tetracycline.  // AHFS Consumer Medication Information;Oct2017, p1 

    Bismuth, metronidazole, and tetracycline is used along with other ulcer medications to treat duodenal ulcers. It is in a class of medications called antibacterial agents. It works by preventing the growth and spread of Helicobacter pylori bacteria, which often occurs with ulcers. Treating this...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics